MedTrace Logo

Ureteral Stenting After Ureteroscopy for Stone Treatment, A Global Perspective on Indications and Outcomes

NCT03567421 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2348

Last updated 2021-04-13

No results posted yet for this study

Summary

Background: The exit strategy after ureteroscopy for stone treatment remains a topic for discussion. Current EAU guidelines on urolithiasis state that postoperative stenting is indicated in patients at increased risk of postoperative complications. Stenting is not considered necessary in all other cases, and after uncomplicated procedures.

Objective: To analyse the postoperative ureteral stenting strategy in clinical practice looking at the indication, type of stents used and the duration of stenting after ureteroscopy for stone treatment. Furthermore, the investigators will examine in what setting the stents are being removed postoperatively.

Study design: This study is a prospective, observational, international, multicentre registry study executed by uCARE.

Study population: All patients \>18 years with a ureter or renal stone who are planned for ureteroscopic treatment by semi-rigid and/or flexible ureteroscopy are eligible for this study.

Conditions

  • Stone;Renal
  • Stone, Kidney
  • Stone Ureter

Sponsors & Collaborators

  • Société Internationale d'Urologie

    lead OTHER

Principal Investigators

  • Joyce Baard, MD · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

  • Mihir Desai, MD · University of Southern California, United States

  • Jean de la Rosette, MD · Istanbul Medipol University, Istanbul, Turkey

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-07
Primary Completion
2019-08-31
Completion
2019-08-31

Countries

  • United States
  • China
  • Greece
  • India
  • Indonesia
  • Iran
  • Iraq
  • Kenya
  • Malaysia
  • Romania
  • Saudi Arabia
  • South Africa
  • South Korea
  • Taiwan
  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03567421 on ClinicalTrials.gov